Article
Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.
Oncotarget - 12 Apr 2016
Yang Xue, Zhuo Minglei, Ye Xin, Bai Hua, Wang Zhijie, Sun Yun, Zhao Jun, An Tongtong, Duan Jianchun, Wu Meina, Wang Jie
Abstract excerpt
PURPOSE: We aimed to investigate the feasibility of droplet digital PCR (ddPCR) for the quantitative and dynamic detection of EGFR mutations and next generation sequencing (NGS) for screening EGFR-tyrosine kinase inhibitors (EGFR-TKIs) resistance-relevant mutations in circulating tumor DNA (ctDNA) from advanced lung adenocarcinoma (ADC) patients. RESULTS: Detection limit of EGFR mutation in ctDNA by ddPCR was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
